1993
DOI: 10.1042/bj2920677
|View full text |Cite
|
Sign up to set email alerts
|

Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram

Abstract: Full-length cDNA for the rat brain rolipram-sensitive cyclic AMP phosphodiesterase (PDE), RD1 was introduced into the expression vector pSVL. COS cells transfected with the recombinant vector pSVL-RD1 exhibited a 30-55% increase in homogenate PDE activity, which was abolished by rolipram (10 microM). Removal of the first 67 nucleotides of the RD1 cDNA yielded a truncated enzyme called Met26-RD1 which lacked the N-terminal first 25 amino acids. Whereas approx. 75% of RD1 activity was membrane-associated, Met26-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

22
186
1

Year Published

1994
1994
2014
2014

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 124 publications
(209 citation statements)
references
References 38 publications
22
186
1
Order By: Relevance
“…2) in the human PDE9A putative regulatory domain (amino acids 1-287) that are absent in the splice variant cloned in mouse. This suggests that alternate splicing of the putative regulatory domain is likely to occur in PDE9A, because it has been observed in other PDE families, where it can alter membrane targeting (16) and interaction with the v-Src SH3 domain (17). The PDE9A regulatory domain is otherwise 98% identical between the species, clearly indicating that these are two members of the same PDE family and almost certainly homologues of the same isozyme.…”
Section: Discussionmentioning
confidence: 85%
“…2) in the human PDE9A putative regulatory domain (amino acids 1-287) that are absent in the splice variant cloned in mouse. This suggests that alternate splicing of the putative regulatory domain is likely to occur in PDE9A, because it has been observed in other PDE families, where it can alter membrane targeting (16) and interaction with the v-Src SH3 domain (17). The PDE9A regulatory domain is otherwise 98% identical between the species, clearly indicating that these are two members of the same PDE family and almost certainly homologues of the same isozyme.…”
Section: Discussionmentioning
confidence: 85%
“…To explain the benefit for the cell of the expression of the multiple isoforms, it needs to be discovered whether functional or regulatory differences between these isoforms exist or whether they are present in different subcellular compartments. In this respect it is interesting to note that rPDE IV-A (RD 1) was found as a membrane-bound isoform [27,28] whereas rPDE IV-D was found in soluble fractions of stimulated Sertoli cells by other authors [13,20].…”
Section: P Engels Et Al Ifebs Letters 350 (1994) 291~95mentioning
confidence: 99%
“…Among PDE4s, the brain-specific supershort PDE4A1 is a unique membrane-associated PDE4 that binds with certain types of lipids (Shakur et al 1993). In PDE4A1, 25 amino acids (aa) of the N terminus are involved in membrane association via two different motifs, namely, helix-1 and helix-2 (Huston et al 2006).…”
mentioning
confidence: 99%